Trials / Withdrawn
WithdrawnNCT01768767
Trial of Ketamine and Lithium Therapy in Bipolar Depression
Novel Approach of Combined Lithium-Ketamine Therapy in Bipolar Depression: To Preserve Efficacy and Minimize Adverse Effects
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is looking at the safety and efficacy of combined ketamine and lithium therapy for treating patients with bipolar depression who are taking a mood stabilizer that is not working for them.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | |
| DRUG | Ketamine | |
| DRUG | Ketamine/Lithium |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2013-01-15
- Last updated
- 2023-03-01
Source: ClinicalTrials.gov record NCT01768767. Inclusion in this directory is not an endorsement.